We came across a bullish thesis on AbCellera Biologics Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc.'s share was trading at $5.15 as of July 21st. ABCL’s trailing P/E was 19.92 according to Yahoo Finance.
[caption id="attachment_1208899" align="aligncenter" width="768"]Abcellera (ABCL) may be nearing an inflection point as ABCL575 and ABCL635 advance to clinical trials, signaling progress toward its...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.